Doxorubicin News Headlines

• Ortho Biotech Seeks FDA Approval For DOXIL(R) In Combination With VELCADE(R) To Treat Relapsed/Refractory Multiple Myeloma
  MedicalNewsToday - Tue, 23 Jan 2007 08:00 EST
  
• Increasing Dose Intensity Of Chemotherapy In Osteosarcoma Offers No Benefit Study Finds
  MedicalNewsToday - Fri, 19 Jan 2007 01:00 EST
  
• No Benefit To Increasing Dose Intensity Of Chemotherapy In Osteosarcoma, Study Finds
  ScienceDaily - Sun, 21 Jan 2007 04:00 EST
  
• Anthracyclines May Not Be For Everyone: Report From The 29th Annual San Antonio Breast Cancer Symposium
  MedicalNewsToday - Tue, 19 Dec 2006 08:00 EST
  
• VELCADE(R) For Injection Based Therapies Show Consistently High Complete And Near Complete Response Rates In Front-Line Multiple Myeloma Trials
  MedicalNewsToday - Wed, 13 Dec 2006 08:00 EST
  
• Interim Analysis Finds DOXIL(R)/VELCADE(R) Combination Significantly Prolongs Time To Progression In Previously Treated Multiple Myeloma Patients
  MedicalNewsToday - Tue, 12 Dec 2006 08:00 EST
  
• Study Showed Epratuzumab In Combination With Rituximab And Chemotherapy Is Safe, Tolerable, And Active In Aggressive Lymphoma
  MedicalNewsToday - Tue, 05 Dec 2006 08:00 EST
  
• Longer Anthracycline Therapy Reduces Heart Failure In Adult Cancer Patients
  MedicalNewsToday - Tue, 28 Nov 2006 04:00 EST
  
• Delcath Systems Announces A New Site For The Phase III Doxorubicin Clinical Trial In San Antonio, TX
  MedicalNewsToday - Sat, 19 Aug 2006 07:00 EST
  
• Study Indicates Heart Damage From Some Cancer Drugs Worsens Over The Years
  MedicalNewsToday - Mon, 24 Jul 2006 05:00 EST
  
• Heart Damage From Some Cancer Drugs Worsens Over The Years Study Indicates
  MedicalNewsToday - Mon, 24 Jul 2006 10:00 EST
  
• Study Indicates Heart Damage From Some Cancer Drugs Worsens Over The Years
  MedicalNewsToday - Wed, 19 Jul 2006 06:00 EST
  
• Nano-particles Effective In Killing Cancer With One-two Punch Of Chemotherapeutics
  ScienceDaily - Mon, 10 Apr 2006 02:00 EST
  
• Supplemental Biologics License Application For First-Line Use Of Rituxan In Low-Grade Or Follicular CD20-Positive B-Cell Non-Hodgkin's Lymphoma
  MedicalNewsToday - Sat, 01 Apr 2006 11:00 EST
  
• Cancer Cells Lose Drug Resistance Following Electrical Stimulation In Vitro
  MedicalNewsToday - Mon, 20 Mar 2006 08:00 EST
  
• Cancer Cells Lose Drug Resistance Following Electrical Stimulation In Vitro
  ScienceDaily - Fri, 17 Mar 2006 03:00 EST
  
• Breast Cancer Chemotherapy Regimen Associated With Life-Threatening Complications
  MedicalNewsToday - Sat, 21 May 2005 04:00 EST